Medici Med. granted formula license

Ra'anana based Medici Medical announced Monday that they have been granted a license by the Health Ministry to begin marketing their recently developed baby formula product in pharmacies across the country.

By MATTHEW KRIEGER
July 31, 2007 07:53

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Ra'anana based Medici Medical announced Monday that they have been granted a license by the Health Ministry to begin marketing their recently developed baby formula product in pharmacies across the country. The formula, called Optimil, was developed in conjunction with Issiney Sant Mar, the largest formula manufacturer in France, and it will compete for the formula market share with Similac and industry leader Materna. Medici was established in 2005 by Yehudit Libel and Shraga Braverman.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS